DV
Dividend Vision

PSNL — Personalis, Inc.

Personalis, Inc. (PSNL)

Total return is -50.7% over the past 7.2 years, 242.7 points behind SPY at 192.0%. Its deepest 1-year drawdown was 55.2%.

Personalis, Inc. is an individual stock in the genomics and precision medicine sector that went public in 2019. The company does not currently pay dividends, making it unsuitable for income-focused investors seeking regular distributions. This equity holding appeals primarily to growth-oriented investors interested in exposure to cancer genomics and personalized medicine technology, rather than those targeting dividend yield.

PSNL key facts

Asset type
Stock
Asset class
Equity
Inception date
06/20/2019
Distribution frequency
None
Last close
$14.04
Market cap
$1,499,470,208
Average volume
1042600.0
Beta
2.285
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.09